Cipla Medpro grabs Mirren
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
Cipla Medpro, the South African subsidiary of Indian generics specialist Cipla, is set to increase its local footprint by acquiring OTC pharmaceutical manufacturer and distributor Mirren in an all cash deal worth ZAR450 million (€29.2 million). Subject to approval by South Africa’s Competition Commission, the deal is scheduled for completion before 30 September.